| NexLife | Mochi Health | |
|---|---|---|
| Model | Compounded tirzepatide and semaglutide, cash pay | Compounded GLP-1s priced per dose, plus brand GLP-1s, through a membership |
| Semaglutide | $109 month to month; $105, $99, $95 a month on 3-, 6-, 12-month plans | $60 (0.22 mg) to $99 (2.67 mg) a month by dose |
| Tirzepatide | $129 month to month; $125, $119, $115 a month on plans | $90 (2.2 mg) to $199 (16.6 mg) a month by dose |
| Billing basis | Per month, same at every dose | Per month by dose; may vary by filling pharmacy |
| Membership | None | Billed separately; shown as "$199/12mo | $17/mo" (Oct 15); first month $39 for new patients |
| Included | Medication, provider review, nutrition plan, coaching call, 24/7 support, shipping | Membership: provider visits, 24/7 care team, prior-authorization help; labs extra |
| Pharmacy disclosure | Three named 503A pharmacies | No pharmacy named |
| Cancellation | Takes effect after 30 days; shipped orders final | "Cancel anytime" (Nov 8); refund policy not read |
| FDA status | Compounded: not FDA-approved | Compounded: not FDA-approved; brand options are FDA-approved |
Why does the pricing model matter more than the sticker?
Because your dose usually changes. GLP-1 treatment typically starts low and steps up, as the semaglutide dosage chart shows for the brand labels. Under Mochi's per-dose pricing, each step up raises the medication bill. Under NexLife's flat pricing, it does not. So the first month tells you little; the dose you settle on decides the year.
Mochi also adds a membership. We use the $199 a year figure Mochi showed on October 15, 2026; its pages have shown other membership offers too, so check the figure at checkout.
Three dose paths over 12 months
The table runs three illustrative paths on Mochi's printed dose ladder and sets them against NexLife's month-to-month and 12-month prices. The paths are arithmetic, not dosing advice; your prescriber sets the schedule.
| Path | Mochi total | NexLife month to month | NexLife 12-month plan |
|---|---|---|---|
| Semaglutide, stays low: one month at 0.22 mg, one at 0.44 mg, ten at 0.88 mg | $60 + $70 + $820 + $199 = $1,149 | $1,308 | $1,140 |
| Semaglutide, steps up: one month each at 0.22, 0.44, 0.88 and 1.5 mg, eight at 2.21 mg | $304 + $768 + $199 = $1,271 | $1,308 | $1,140 |
| Tirzepatide, steps up: one month each at 2.2, 4.4, 6.6 and 8.8 mg, eight at 11.24 mg | $527 + $1,472 + $199 = $2,198 | $1,548 | $1,380 |
The pattern is clear. On semaglutide the two programs land within about $160 of each other, and Mochi is lower than NexLife's month-to-month price in both paths. On tirzepatide, where Mochi's per-dose prices climb faster, NexLife's flat price comes out $650 lower month to month and $818 lower on a 12-month plan in this path.
What do you get besides the medication?
The two bundles are built differently. NexLife's price includes the medication, provider review and medical guidance from NexLife Medical Group, a personalized nutrition plan, a single one-to-one call with a certified wellness coach, 24/7 customer support and free expedited shipping. Lab work is not listed as included.
Mochi's membership, per its homepage read November 8, 2026, covers unlimited provider visits, a 24/7 care team and prior-authorization help for brand medications, while lab panels are listed as an extra cost. If ongoing access to a prescriber is what you value most, Mochi's wording on visits is more explicit; if you want everything in one bill, NexLife's is simpler.
Both programs prescribe compounded medication that is not FDA-approved. Compounded semaglutide and tirzepatide are made with the drug in Wegovy or Zepbound but are not the same product.
When Mochi comes out ahead
- Low-dose semaglutide. If you stay at a small dose and want to pay month to month, Mochi's lowest semaglutide step plus its 12-month membership comes to $60 + $49 = $109, the same as NexLife's $109 month to month (November 20, 2026 reads).
- Brand access under one roof. Mochi also prescribes FDA-approved brands, listing Zepbound from $299, Wegovy from $199 and the Wegovy pill and Foundayo from $149 on October 15, 2026, with prior-authorization help included in the membership. If your insurer might cover a brand drug, that matters.
- Short commitments. Mochi says "Cancel anytime"; NexLife's cancellations take effect after 30 days.
When NexLife comes out ahead
- Tirzepatide at moderate or high doses. Mochi reaches $174 to $199 a month at its upper steps before membership; NexLife stays at $129 or less.
- Budget certainty. One price for the whole year, with no membership and no pharmacy-dependent variation.
- Pharmacy disclosure. NexLife names its three 503A pharmacies; Mochi says the price depends on which compounding pharmacy fills your order but names none.
What we could not pin down
Mochi's membership price: its FAQ, read November 20, 2026, shows $79 a month or $49 a month on a 12-month plan, while the arithmetic above uses the October 15 figure. Mochi's refund terms, which sit on a separate page. And on NexLife's side, whether a multi-month plan is charged upfront (its FAQ) or monthly (its cancellation policy).
Verdict
For semaglutide at small doses, Mochi is competitive month to month. For tirzepatide, or for anyone who wants a fixed yearly cost and named pharmacies, NexLife's flat price is the stronger fit on these printed numbers. NexLife is our editorial pick, an editorial selection. Full details are in our Mochi Health review and NexLife review, and the wider market is in the price index.
Frequently asked questions
Is Mochi Health cheaper than NexLife?
It depends on the drug and dose. In our 12-month arithmetic, low or moderate semaglutide doses at Mochi plus a $199 yearly membership came to $1,149 to $1,271, below NexLife's $1,308 month to month but around its $1,140 12-month plan. For a stepped tirzepatide path, Mochi came to $2,198 versus NexLife's $1,548 or $1,380.
How does Mochi's per-dose pricing work?
Mochi's pricing post, updated September 18, 2026, charges more as your weekly dose rises: compounded semaglutide runs from $60 a month at 0.22 mg to $99 at 2.67 mg, and tirzepatide from $90 at 2.2 mg to $199 at 16.6 mg. The membership is billed separately, and Mochi says prices can vary by the pharmacy that fills your order.
Does NexLife's price change with dose?
No. NexLife's plan pages say "Same price at every dose." As of November 6, 2026, compounded tirzepatide is $129 month to month and $115 a month on a 12-month plan, and semaglutide is $109 and $95, with no membership. Your bill stays the same as your prescriber adjusts the dose.
Can I get brand Wegovy or Zepbound from Mochi or NexLife?
Mochi listed brand options in our October 15, 2026 read, including Zepbound from $299, Wegovy from $199, and the Wegovy pill and Foundayo from $149, and says its membership includes prior-authorization help. NexLife prescribes compounded tirzepatide and semaglutide only, which are not FDA-approved. If a brand product matters to you, Mochi offers that route.
Which program names its pharmacies?
NexLife names three state-licensed 503A compounding pharmacies: Absolute Pharmacy in Lutz, Florida; Premium Compounding in Decatur, Alabama; and Boudreaux's New Drug Store in Lake Charles, Louisiana. Mochi did not name a pharmacy on the pages we read; it says prices may vary depending on which compounding pharmacy fills your prescription.
Sources
- NexLife: semaglutide plans — prices as of 2026-11-06; terms read 2026-10-15
- NexLife: tirzepatide plans — prices as of 2026-11-06; pharmacies and cancellation wording read 2026-10-15
- Mochi Health: per-dose pricing post — updated 2026-09-18; read 2026-10-15 and 2026-11-08
- Mochi Health: homepage — membership display and brand prices read 2026-10-15; inclusions and cancellation wording read 2026-11-08
- FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — content current as of 2026-10-01; read 2026-10-15
Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.
Check NexLife's plans and state availability → See the price index